Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: 4Health

This article was originally published in The Tan Sheet

Executive Summary

4Health: Introducing Nature's Secret Rezyme, a two-part "digestive program" consisting of a "high-potency vegetarian enzyme that enhances the digestion of all vital food groups, including protein, fats, carbohydrates and dairy," and "a natural digestive rebuilder composed of herbs and nutrients designed to strengthen and rebuild the body's own digestive system," the Boulder, Colo.-based dietary supplement firm says. Another new product, Nature's Secret Candistroy, is a two-part program "designed to combat Candida as well as replenish the intestinal system with beneficial bacteria," 4Health claims. Both products are being introduced in health food stores, including GNC, nationwide. A 15-25 day supply, consisting of 150 tablets (75 tablets of each part) of Rezyme is $19.95 suggested retail and Candistroy is $25.95. A print ad campaign for the products is slated to commence in the fall. Ads for Rezyme will run in books including Energy Times, Natural Health, Delicious, Vegetarian Times and New Age Journal starting in September, and Candistroy ads will break in October...

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts